Professor Dagmar Fischer from the Friedrich Schiller University of Jena is the new president of the German Pharmaceutical Society (DPhG).

In addition to her studies on the interaction of nanoparticulate drug forms with different cell types and biological barriers, such as human skin or intestines, Dagmar Fischer is also researching alternative models to animal experiments.